Efficacy and safety of Aviron Rapid® in adolescents and children with viral acute upper respiratory tract infection: a multi-center, randomized, double blind, placebo-controlled clinical trial


	Secondary endpoints: Percentage of patients with persistent decrease of temperature <37°C (Efficacy Analysis). P-values from 1-sided 2-proportion Z-test.

Part of: Markova RM, Tzotcheva IS, Perenovska P, Mangarov A, Nikolaeva-Glomb L, Hadjiev V (2023) Efficacy and safety of Aviron Rapid® in adolescents and children with viral acute upper respiratory tract infection: a multi-center, randomized, double blind, placebo-controlled clinical trial. Folia Medica 65(4): 546-568. https://doi.org/10.3897/folmed.65.e108153